Biological Marker(s)
Antibody or DNA/RNA
Window Period
90 days
Sample Required
Blood from vein
Turn Around Time
7 working days (exc. sat/sun & holidays)
Locations
Fees
£250
Journey Overview

There are an estimated 5–10 million people living with HTLV-1 worldwide, although the true prevalence is uncertain because surveillance is limited. HTLV-1 is more common in certain regions, including parts of Brazil. Most people infected with HTLV-1 have no symptoms or signs and may not know they are infected. A small minority, approximately 1 in 20 people, will develop complications, which usually occur several decades after infection.
In the UK, HTLV is a rare infection and is not routinely included in STI or antenatal screening. However, HTLV screening is routinely undertaken in blood donation and organ transplantation services, as well as in specialist medical practice including neurology, haematology and oncology.
Where required, an HTLV antibody screening test is recommended. If the antibody screening test is reactive, confirmatory testing is required. This may include confirmatory serology and/or PCR to detect HTLV proviral DNA, helping to confirm infection and distinguish between HTLV-1 and HTLV-2. HTLV-1 is a lifelong infection, so PCR is not used to determine whether an infection is “active” or “resolved” in the same way as some viral RNA tests.
#1 Pre-Appointment Questionnaire
To help make your appointment as efficient and informative as possible, we ask you to complete a short questionnaire before attending.
#2 Consultation
We will begin by assessing your medical & sexual history, any symptoms you may be experiencing and discuss any questions you may have.
#3 Sample Collection
If it is still appropriate to proceed with the HTLV test (and you would like to), we will take a blood sample from the vein.
For a recent exposure, testing timing/window period should be considered and repeat testing may be required if the initial antibody test is performed too early.
#4 Receive Results
Once you have received your results, we will discuss what they mean and any appropriate next steps with you. If HTLV infection is confirmed, this may include discussing testing of current and, where appropriate, previous sexual partners.
Patient Feedback
Eligibility
Best For
Screening following potential exposure to HTLV-1 or HTLV-2
Pregnancy/Breastfeeding
Testing identifies HTLV infection to help reduce mother-to-child transmission.
Menstruation
Menstruation does not affect HTLV test results.
Prior/Repeat Use
To confirm current infection
Do NOT use if
You have symptoms requiring clinical assessment or specialist advice.
Avoid/Discuss if
Recent or possible HTLV exposure, pregnancy, or breastfeeding concerns.
FAQs
HTLV is diagnosed with a blood test that checks for antibodies to HTLV-1 and HTLV-2. A blood sample is taken from a vein in your arm and sent to a laboratory for analysis.
For the most reliable result, it is usually recommended to wait at least 12 weeks after a potential exposure, as it can take time for antibodies to become detectable. If the screening test is reactive, further confirmatory testing is carried out to confirm the diagnosis.
Preparing for an HTLV test is simple. You do not need to fast and can eat and drink as normal before your appointment.
To make the blood test easier, it is helpful to:
• Drink plenty of water before your appointment.
• Wear clothing with sleeves that can be rolled up easily.
• Bring photo identification if the test is required for official purposes.
If you are testing after a possible exposure, testing at or after 12 weeks provides the most reliable antibody result following a recent exposure; earlier testing may require repeating.
The window period for HTLV testing is 12 weeks (3 months) after a potential exposure.
This is the time your body needs to produce enough antibodies for the test to detect them accurately. Testing earlier may result in a false-negative result, and repeat testing may be recommended if the exposure was recent.
HTLV testing usually begins with an antibody blood test. This detects antibodies produced by your immune system after exposure to HTLV-1 or HTLV-2.
If the initial result is reactive, additional confirmatory tests may be performed. In some situations, a PCR (Polymerase Chain Reaction) test is used to detect HTLV proviral DNA in infected cells, helping confirm the diagnosis and identify the type of HTLV present.
HTLV antibody screening tests are highly sensitive. However, a reactive screening result is not diagnostic on its own and requires confirmatory testing to verify the result.
For the most accurate result, you should be tested 3 months after a potential exposure.
If you are tested before this window period, a negative or non-reactive antibody result may not exclude a recent HTLV infection. If there has been a recent potential exposure, repeat testing at 3 months may be recommended.
Testing may be appropriate if you have:
• Had sexual contact with someone known to have HTLV.
• Shared injecting equipment.
• Been born in or lived in a region where HTLV is more common, particularly where there are other relevant risk factors or exposures.
• Been advised to test as part of a healthcare or specialist assessment.
UK blood donations are routinely screened for HTLV, while testing for organ donation is managed through the relevant donation and transplant pathway.
If you are unsure whether testing is appropriate, a healthcare professional can help assess your risk and advise on the best timing.
Usually not. An HTLV test only requires a blood sample.
If you have symptoms or other health concerns, a healthcare professional may recommend an examination as part of your assessment, but this is not routinely required for HTLV testing.
Yes. The type of test depends on the clinical situation.
The main tests include:
• HTLV-1/HTLV-2 antibody test – the standard screening blood test.
• Confirmatory testing – performed if the screening test is reactive to confirm the result. This may include confirmatory serology and, where appropriate, molecular testing.
• HTLV proviral DNA PCR – detects HTLV proviral DNA and may be used in appropriate clinical situations to help confirm infection and distinguish between HTLV-1 and HTLV-2.
Your healthcare provider will recommend the most appropriate testing based on your circumstances.
You can receive your test results by either text or email.
The results will be either NOT Detected (i.e. negative) or DETECTED (i.e. positive).
In some cases, the test may come back as equivocal which means that it was not possible to gain a conclusive result from the sample given. If this happens, we will request another sample free of charge.
If you have had a significant potential exposure to HTLV, your clinician can advise whether any precautions are appropriate while awaiting your result.
Where relevant, you should:
• Use condoms or avoid sexual activity until you have discussed your individual circumstances with a healthcare professional.
• Avoid sharing needles or injecting equipment.
• Avoid donating blood while you are being investigated for a possible blood-borne infection.
Organ donation suitability is assessed by the relevant transplant service.
A reactive HTLV screening test does not by itself confirm an HTLV infection. Confirmatory testing is required before a diagnosis is made.
If HTLV-1 infection is confirmed, you will be referred for appropriate specialist assessment and ongoing follow-up. HTLV-1 is a lifelong infection, and there is currently no cure, although most people with HTLV-1 do not develop related health problems.
You will receive advice on reducing the risk of transmission to others. This may include using condoms and avoiding shared injecting equipment. Blood donation should be avoided. Organ donation suitability is assessed by the relevant transplant service.
If you are pregnant or considering breastfeeding, you should receive specialist advice about infant feeding because HTLV-1 can be transmitted through breast milk.
Testing of current or previous sexual partners may also be appropriate depending on the exposure history.
Current sexual partners should be advised to discuss HTLV testing with a healthcare professional. Testing of previous partners may also be appropriate depending on the exposure history.
If you need support with partner notification or discussing your diagnosis, your healthcare provider can offer confidential advice.
Yes. A certificate of your HTLV test results can be provided if you need official documentation for purposes such as employment, travel, or insurance.
You will usually need to provide a valid form of photo identification, such as a passport or driving licence, so your identity can be verified on the certificate. The certificate is issued once your laboratory results are available.
Page last reviewed by Mrs Magdalena Nowacka 17 September 2026 for general guidance only. It is not intended to replace the advice of your clinician.